# Respiratory viral infections research

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/respiratory-viral-infections-research/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers explores the epidemiology, pathogenesis, and clinical impact of respiratory viral infections, with a focus on Respiratory Syncytial Virus (RSV), Human Metapneumovirus, bronchiolitis, viral pneumonia, and influenza virus. It covers topics such as disease burden, vaccine development, host immune response, and the impact of these infections on different age groups. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11243 |
| Works | 299 |

## Topic papers all

Showing 15 of 299.

- [Estimates of global seasonal influenza-associated respiratory mortality: a modelling study](https://scholariq.org/papers/estimates-of-global-seasonal-influenza-associated-respiratory-mortality-a/)
- [Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19](https://scholariq.org/papers/single-cell-landscape-of-bronchoalveolar-immune-cells-in-patients-with-covid-19/)
- [Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus](https://scholariq.org/papers/human-infection-with-a-novel-avian-origin-influenza-a-h7n9-virus/)
- [Guidelines for the Management of Adults with Community-acquired Pneumonia](https://scholariq.org/papers/guidelines-for-the-management-of-adults-with-community-acquired-pneumonia/)
- [American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis](https://scholariq.org/papers/american-thoracic-society-centers-for-disease-control-and-prevention-infectious/)
- [Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis](https://scholariq.org/papers/clinical-practice-guideline-the-diagnosis-management-and-prevention-of/)
- [Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003](https://scholariq.org/papers/epidemiology-and-cause-of-severe-acute-respiratory-syndrome-sars-in-guangdong/)
- [Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study](https://scholariq.org/papers/experimental-treatment-with-favipiravir-for-covid-19-an-open-label-control-study/)
- [Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study](https://scholariq.org/papers/estimated-global-mortality-associated-with-the-first-12-months-of-2009-pandemic/)
- [Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents](https://scholariq.org/papers/severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-infection-in-children/)
- [A distinct lineage of influenza A virus from bats](https://scholariq.org/papers/a-distinct-lineage-of-influenza-a-virus-from-bats/)
- [The Efficacy of Influenza Vaccine in Elderly Persons](https://scholariq.org/papers/the-efficacy-of-influenza-vaccine-in-elderly-persons/)
- [In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses](https://scholariq.org/papers/in-vitro-and-in-vivo-characterization-of-new-swine-origin-h1n1-influenza-viruses/)
- [Cigarette Smoking and Infection](https://scholariq.org/papers/cigarette-smoking-and-infection/)
- [ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques](https://scholariq.org/papers/chadox1-ncov-19-vaccine-prevents-sars-cov-2-pneumonia-in-rhesus-macaques/)

## Topic primary papers

Showing 15 of 73.

- [Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis](https://scholariq.org/papers/clinical-practice-guideline-the-diagnosis-management-and-prevention-of/)
- [Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection](https://scholariq.org/papers/updated-guidance-for-palivizumab-prophylaxis-among-infants-and-young-children-at/)
- [Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-regional-and-national-incidence-and-mortality-burden-of-non-covid-19/)
- [Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study](https://scholariq.org/papers/respiratory-viruses-in-exacerbations-of-chronic-obstructive-pulmonary-disease/)
- [A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge](https://scholariq.org/papers/a-double-inactivated-severe-acute-respiratory-syndrome-coronavirus-vaccine/)
- [Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study](https://scholariq.org/papers/global-burden-of-respiratory-infections-associated-with-seasonal-influenza-in/)
- [Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing](https://scholariq.org/papers/viral-infections-in-relation-to-age-atopy-and-season-of-admission-among-children/)
- [The Association of Newly Identified Respiratory Viruses with Lower Respiratory Tract Infections in Korean Children, 2000–2005](https://scholariq.org/papers/the-association-of-newly-identified-respiratory-viruses-with-lower-respiratory/)
- [Glucocorticoids for acute viral bronchiolitis in infants and young children](https://scholariq.org/papers/glucocorticoids-for-acute-viral-bronchiolitis-in-infants-and-young-children/)
- [Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract](https://scholariq.org/papers/development-of-motavizumab-an-ultra-potent-antibody-for-the-prevention-of/)
- [Epidemiology of Acute Respiratory Infections in Children of Developing Countries](https://scholariq.org/papers/epidemiology-of-acute-respiratory-infections-in-children-of-developing-countries/)
- [A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants](https://scholariq.org/papers/a-highly-potent-extended-half-life-antibody-as-a-potential-rsv-vaccine-surrogate/)
- [A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults](https://scholariq.org/papers/a-novel-investigational-fc-modified-humanized-monoclonal-antibody-motavizumab/)
- [Association between Common Toll‐Like Receptor 4 Mutations and Severe Respiratory Syncytial Virus Disease](https://scholariq.org/papers/association-between-common-toll-like-receptor-4-mutations-and-severe-respiratory/)
- [Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019](https://scholariq.org/papers/age-sex-differences-in-the-global-burden-of-lower-respiratory-infections-and/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.